These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 11509113)
1. Serological Immunoglobulin G antibody titers to Helicobacter pylori in Japanese Brazilian and Non-Japanese Brazilian gastric cancer patients and controls in São Paulo. Fujioka N; Fahey MT; Hamada GS; Nishimoto IN; Kowalski LP; Iriya K; Rodrigues JJ; Tajiri H; Tsugane S Jpn J Cancer Res; 2001 Aug; 92(8):829-35. PubMed ID: 11509113 [TBL] [Abstract][Full Text] [Related]
2. Ethnic difference in serology of Helicobacter pylori CagA between Japanese and non-Japanese Brazilians for non-cardia gastric cancer. Tatemichi M; Hamada GS; Nishimoto IN; Kowalski LP; Iriya K; Rodrigues JJ; Tsugane S Cancer Sci; 2003 Jan; 94(1):64-9. PubMed ID: 12708476 [TBL] [Abstract][Full Text] [Related]
3. Immune responses against Helicobacter pylori in gastric cancer patients and in risk groups for gastric cancer. Adamsson J; Lundin SB; Hansson LE; Sjövall H; Svennerholm AM Helicobacter; 2013 Feb; 18(1):73-82. PubMed ID: 23067268 [TBL] [Abstract][Full Text] [Related]
4. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study. Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S; Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of IgG antibody titer against Helicobacter pylori. Tatemichi M; Sasazuki S; Inoue M; Tsugane S; Helicobacter; 2009 Jun; 14(3):231-6. PubMed ID: 19702853 [TBL] [Abstract][Full Text] [Related]
6. Lifestyle factors associated with atrophic gastritis among Helicobacter pylori-seropositive Japanese-Brazilians in São Paulo. Ito LS; Oba-Shinjo SM; Marie SK; Uno M; Shinjo SK; Hamajima N; Tajima K; Tominaga S Int J Clin Oncol; 2003 Dec; 8(6):362-8. PubMed ID: 14663638 [TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori IgA and IgG antibodies, serum pepsinogen I and the risk of gastric cancer: changes in the risk with extended follow-up period. Knekt P; Teppo L; Aromaa A; Rissanen H; Kosunen TU Int J Cancer; 2006 Aug; 119(3):702-5. PubMed ID: 16496404 [TBL] [Abstract][Full Text] [Related]
8. Associations of a PTPN11 G/A polymorphism at intron 3 with Helicobactor pylori seropositivity, gastric atrophy and gastric cancer in Japanese. Hishida A; Matsuo K; Goto Y; Naito M; Wakai K; Tajima K; Hamajima N BMC Gastroenterol; 2009 Jul; 9():51. PubMed ID: 19589142 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of non-cardia gastric cancer with a high serum anti-Helicobacter pylori IgG titer and its association with diffuse-type histology. Gong EJ; Lee JY; Bae SE; Park YS; Choi KD; Song HJ; Lee GH; Jung HY; Jeong WJ; Cheon GJ; Yook JH; Kim BS PLoS One; 2018; 13(4):e0195264. PubMed ID: 29621300 [TBL] [Abstract][Full Text] [Related]
10. Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen. Tatemichi M; Sasazuki S; Inoue M; Tsugane S; Acta Oncol; 2008; 47(3):360-5. PubMed ID: 18347999 [TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project. González CA; Megraud F; Buissonniere A; Lujan Barroso L; Agudo A; Duell EJ; Boutron-Ruault MC; Clavel-Chapelon F; Palli D; Krogh V; Mattiello A; Tumino R; Sacerdote C; Quirós JR; Sanchez-Cantalejo E; Navarro C; Barricarte A; Dorronsoro M; Khaw KT; Wareham N; Allen NE; Tsilidis KK; Bas Bueno-de-Mesquita H; Jeurnink SM; Numans ME; Peeters PHM; Lagiou P; Valanou E; Trichopoulou A; Kaaks R; Lukanova-McGregor A; Bergman MM; Boeing H; Manjer J; Lindkvist B; Stenling R; Hallmans G; Mortensen LM; Overvad K; Olsen A; Tjonneland A; Bakken K; Dumeaux V; Lund E; Jenab M; Romieu I; Michaud D; Mouw T; Carneiro F; Fenge C; Riboli E Ann Oncol; 2012 May; 23(5):1320-1324. PubMed ID: 21917738 [TBL] [Abstract][Full Text] [Related]
13. Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Aromaa A; Kosunen TU; Knekt P; Maatela J; Teppo L; Heinonen OP; Härkönen M; Hakama MK Am J Epidemiol; 1996 Jul; 144(2):142-9. PubMed ID: 8678045 [TBL] [Abstract][Full Text] [Related]
14. Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects. Yamaji Y; Mitsushima T; Ikuma H; Okamoto M; Yoshida H; Kawabe T; Shiratori Y; Saito K; Yokouchi K; Omata M Gut; 2001 Sep; 49(3):335-40. PubMed ID: 11511553 [TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori infection and atrophic gastritis in middle-aged Japanese residents of São Paulo and Lima. Tsugane S; Fahey MT; Hamada GS; Kabuto M; Miyakawa VY Int J Epidemiol; 1999 Jun; 28(3):577-82. PubMed ID: 10405867 [TBL] [Abstract][Full Text] [Related]
16. Capsaicin consumption, Helicobacter pylori positivity and gastric cancer in Mexico. López-Carrillo L; López-Cervantes M; Robles-Díaz G; Ramírez-Espitia A; Mohar-Betancourt A; Meneses-García A; López-Vidal Y; Blair A Int J Cancer; 2003 Aug; 106(2):277-82. PubMed ID: 12800206 [TBL] [Abstract][Full Text] [Related]
17. Lack of association of Helicobacter pylori seroprevalence and gastric cancer in a population with low gastric cancer incidence. Rudi J; Müller M; von Herbay A; Zuna I; Raedsch R; Stremmel W; Räth U Scand J Gastroenterol; 1995 Oct; 30(10):958-63. PubMed ID: 8545615 [TBL] [Abstract][Full Text] [Related]
18. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Wu AH; Crabtree JE; Bernstein L; Hawtin P; Cockburn M; Tseng CC; Forman D Int J Cancer; 2003 Mar; 103(6):815-21. PubMed ID: 12516104 [TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 4 +3725 G/C polymorphism, Helicobacter pylori seropositivity, and the risk of gastric atrophy and gastric cancer in Japanese. Hishida A; Matsuo K; Goto Y; Mitsuda Y; Hiraki A; Naito M; Wakai K; Tajima K; Hamajima N Helicobacter; 2009 Feb; 14(1):47-53. PubMed ID: 19191896 [TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. Ye W; Held M; Lagergren J; Engstrand L; Blot WJ; McLaughlin JK; Nyrén O J Natl Cancer Inst; 2004 Mar; 96(5):388-96. PubMed ID: 14996860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]